MedTrace Logo

Comparative Efficacy and Tolerability of No7 in Osteoarthritis of the Knee

NCT03442153 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2018-02-22

No results posted yet for this study

Summary

This study evaluates the effect of dietary supplement Solgar No7 in 76 adult Osteoarthritis of the Knee Patients, while the other half will receive placebo.

Conditions

  • Osteoarthritis, Knee

Interventions

DIETARY_SUPPLEMENT

Solgar No7 Complex

Solgar No7 Capsules

DIETARY_SUPPLEMENT

placebo

Placebo tablets Cellulose

Sponsors & Collaborators

  • Ambrosia - SupHerb Ltd.

    lead INDUSTRY

Principal Investigators

  • Guy Rubin · HaEmek Medical Center, Israel

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-31
Primary Completion
2018-05-31
Completion
2018-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03442153 on ClinicalTrials.gov